Ticker Details
Axsome Therapeutics, Inc. Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system.
IPO Date:	November 19, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$12.14B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.26 | 2.90%
Avg Daily Range (30 D):	$3.51 | 1.75%
Avg Daily Range (90 D):	$2.84 | 1.56%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.66M
Avg Daily Volume (90 D):	.54M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	3,729
Avg Institutional Trade:	$3.62M
Avg Institutional Trade (30 D):	$10.52M
Avg Institutional Trade (90 D):	$11.18M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.63M
Avg Closing Trade (30 D):	$20.01M
Avg Closing Trade (90 D):	$16.34M
Avg Closing Volume:	55.81K

News

May 8, 2026 @ 11:30 AM 3 Stocks Poised to Disrupt the Healthcare Market b... Source: Jeff Siegel

May 5, 2026 @ 11:00 AM Axsome Therapeutics to Participate in Upcoming Inv... Source: Na

May 4, 2026 @ 11:30 AM Hypercharge Grows Total Charging Ports by over 45%... Source: Globe Newswire

Apr 8, 2026 @ 11:00 AM Axsome Therapeutics to Report First Quarter 2026 F... Source: Not Specified

Mar 25, 2026 @ 9:24 PM Prediction: 2 Stocks That Will Be Worth More Than ... Source: Prosper Junior Bakiny

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.72	$-1.26	$-.55
Diluted EPS	$-3.72	$-1.26	$-.55
Revenue	$708.24M	$191.2M	$196M
Gross Profit
Net Income / Loss	$-188.3M	$-64.54M	$-28.56M
Operating Income / Loss	$-173.14M	$-63.36M	$-26.96M
Cost of Revenue
Net Cash Flow	$4.2M	$-17.83M	$-2.34M
PE Ratio